Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fitstry vs UR Meds

Fitstry
Graded #292

Higher grade

vs+6.600000000000001
UR Meds
Graded #452

Lower grade

The verdict

Fitstry takes it — 61.5/100 to 54.9/100.

Fitstry grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fitstry is the GLP-1 weight-loss program of Weightstry, LLC, a LegitScript-certified, cash-pay telehealth practice focused on women 40+.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueUR Meds +15
30
45
Dose & formulationFitstry +35
75
40
Clinical oversightFitstry +3
81
78
Labs & monitoringFitstry +20
73
53
FulfillmentFitstry +3
67
64
Contract termsUR Meds +8
47
55
Fitstry · left barUR Meds · right bar

The numbers

MetricFitstryUR Meds
WeighScore61.5/10054.9/100
GradeCC
Scorecard rank#292#452
Semaglutide$179/mo (annual plan, plus a separate fee, compounded)Not disclosed
Tirzepatide$269/mo (annual plan, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Fitstry

Graded #292 · C

Strengths

  • Transparent pricing before you commit — compounded semaglutide from $179/mo, tirzepatide from $269/mo, oral GLP-1 from $209/mo (annual plan)
  • Free screening with a one-time $99 program fee that is fully refunded if a clinician can't prescribe ('Approved, or Your $99 Back')
  • Monthly price bundles a lab panel (CMP, A1c, lipids, TSH), unlimited clinician access, bi-weekly care coaching and a 24/7 Care Line
  • Runs under Weightstry, LLC, a LegitScript-certified practice with an independently verifiable seal, a named support email and phone
  • Full compounded lineup — weekly injection, daily oral tablet and microdosing options

Where it loses points

  • Month-to-month pricing is notably higher than the annual plan ($249 vs $179 semaglutide, $339 vs $269 tirzepatide)
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Framed for women 40+, and serves 49 states rather than all 50 (the excluded state isn't disclosed publicly)
  • Works with state-licensed compounding pharmacies but doesn't name a specific pharmacy partner on the Fitstry page
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
UR Meds

Graded #452 · C

Strengths

  • GLP-1 weight-loss care from $179/mo with the same price at every dose
  • No monthly membership; cancel anytime; no insurance required
  • Multi-pillar: also peptides, men's/women's health, hair, and longevity
  • Runs on the OpenLoop Health telehealth platform with US-licensed providers
  • 10,000+ patients served

Where it loses points

  • Specific GLP-1 molecule (semaglutide vs tirzepatide) not named on the marketing site
  • Compounding pharmacy partner not named
  • States of operation not published
  • LegitScript 'Certified' shown via a self-hosted badge linking to the generic LegitScript site (not independently verifiable)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard